Antiretroviral Therapy and Adverse Pregnancy Outcomes in People Living with HIV | New
England Journal of Medicine Skip to main content The New England Journal of Medicine …

Abstract Purpose of Review The population of HIV-exposed uninfected (HEU) children is
expanding rapidly, and over one million HEU infants are born each year globally. Several …

Importance Maternal antiretroviral treatment (ART) started before conception may increase
the risk for adverse birth outcomes among women with human immunodeficiency virus (HIV) …

Almost 25 years since antiretroviral therapy (ART) was first shown to prevent mother-to-child
transmission of HIV, 76% of pregnant women living with HIV (over 1 million women) receive …

Background Studies of antiretroviral therapy (ART) use during pregnancy in HIV-infected
women have suggested that ART exposure may be associated with adverse birth outcomes …

Summary Background The World Health Organization recommends protease inhibitor (PI)-
based antiretroviral therapy (ART) as second-line and third-line regimens in pregnant …

Prior to widespread availability of antiretroviral therapy (ART) in sub-Saharan Africa,
children who were HIV-exposed but uninfected (HEU) had increased mortality, morbidity …

Introduction Antiretroviral therapy‐naïve pregnant women living with HIV are at an increased
risk for adverse pregnancy outcomes. It remains controversial whether this risk persists with …

As antiretroviral therapy (ART) expands in resource-limited settings, understanding the
impact of ART on pregnancy outcomes is critical. We analyzed women who became …

The implementation of the 2013 World Health Organization Option B+ recommendations for
HIV treatment during pregnancy has helped drive significant progress in achieving universal …